Abbott Laboratories (NYSE:ABT) ranks among the best medical device stocks to invest in. Benchmark began coverage of Abbott ...

Abbott Laboratories (ABT) reports robust earnings with significant contributions from medical devices and new product ...

Q3 2025 Earnings Call Transcript October 15, 2025 Abbott Laboratories reports earnings inline with expectations. Reported EPS ...

Abbott Laboratories (ABT) stock drops as the company's Q3 2025 results miss revenue estimates as diagnostics unit contracts ...

Abbott’s strong Q3, global diversification, and resilient portfolio support long-term growth despite diagnostics softness and ...

Medical devices continue to be a strong growth driver for Abbott, as the company battles its ongoing sales slump in ...

Abbott stock fell as Q3 sales missed estimates and 2025 earnings guidance was narrowed despite solid growth in medical ...

Abbott Laboratories ( ($ABT) ) has released its Q3 earnings. Here is a breakdown of the information Abbott Laboratories ...

Abbott Laboratories (NYSE:ABT) produces a wide range of healthcare products and medical devices, with its business divided into four main areas: established pharmaceuticals, diagnostics, nutrition, ...

Abbott trimmed its earnings forecast as the Trump administration launched an investigation into medical device imports that ...

Health Canada is willing to consider approving home COVID-19 tests to screen for the virus, a spokesman for the minister of health told Reuters, in a win for public health experts and doctors who have ...